BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2026 9:40:36 AM | Browse: 2 | Download: 0
 |
Received |
|
2026-01-27 10:03 |
|
Peer-Review Started |
|
2026-01-27 10:04 |
|
First Decision by Editorial Office Director |
|
2026-02-10 08:56 |
|
Return for Revision |
|
2026-02-10 08:56 |
|
Revised |
|
2026-02-21 10:02 |
|
Publication Fee Transferred |
|
2026-02-27 10:26 |
|
Second Decision by Editor |
|
2026-04-08 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-08 03:55 |
|
Articles in Press |
|
2026-04-08 03:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-19 01:03 |
|
Publish the Manuscript Online |
|
2026-07-13 09:40 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
OncoVee™-mini-patient-derived xenograft guided adjuvant chemotherapy treatment for resectable gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu-Xuan Qiu, Kai-Yu Jian, Qian-Ru Xu, Xin Lu, Bao-Lei Jia, Lin Jiang and Feng Liang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Feng Liang, Academic Fellow, PhD, Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. lfpeakcool@126.com |
| Key Words |
Gastric cancer; OncoVee™-mini patient-derived xenograft; Overall survival; Postoperative adjuvant chemotherapy; Recurrence-free survival |
| Core Tip |
In this retrospective study, OncoVee™-mini patient-derived xenograft-guided postoperative adjuvant chemotherapy significantly improved recurrence-free survival and overall survival in patients with resectable gastric cancer compared with conventional experience-based treatment. The mini patient-derived xenograft platform enables rapid in vivo drug sensitivity testing within 7 days and may provide a feasible strategy for individualized precision chemotherapy selection in clinical practice. |
| Publish Date |
2026-07-13 09:40 |
| Citation |
Qiu YX, Jian KY, Xu QR, Lu X, Jia BL, Jiang L, Liang F. OncoVee™-mini-patient-derived xenograft guided adjuvant chemotherapy treatment for resectable gastric cancer. World J Gastrointest Oncol 2026; 18(7): 118050
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i7/118050.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i7.118050 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
